K. Jokelainen

1.1k total citations
15 papers, 727 citations indexed

About

K. Jokelainen is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Nutrition and Dietetics. According to data from OpenAlex, K. Jokelainen has authored 15 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 10 papers in Molecular Biology and 3 papers in Nutrition and Dietetics. Recurrent topics in K. Jokelainen's work include Alcohol Consumption and Health Effects (12 papers), Gut microbiota and health (7 papers) and Liver Disease Diagnosis and Treatment (2 papers). K. Jokelainen is often cited by papers focused on Alcohol Consumption and Health Effects (12 papers), Gut microbiota and health (7 papers) and Liver Disease Diagnosis and Treatment (2 papers). K. Jokelainen collaborates with scholars based in Finland, United States and United Kingdom. K. Jokelainen's co-authors include Mikko Salaspuro, T. Nosova, R. Heine, Hannele Jousimies–Somer, Risto P. Roine, Martti Färkkilâ, Pertti Kaihovaara, A. Siitonen, Tiina Koivisto and Päivi Kärkkäinen and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Gut and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

K. Jokelainen

15 papers receiving 691 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Jokelainen Finland 13 429 288 167 137 99 15 727
Satu Väkeväinen Finland 12 327 0.8× 169 0.6× 116 0.7× 123 0.9× 55 0.6× 13 544
Sang Hak Han South Korea 16 208 0.5× 495 1.7× 397 2.4× 96 0.7× 183 1.8× 35 932
T. Nosova Finland 9 267 0.6× 197 0.7× 101 0.6× 55 0.4× 57 0.6× 12 450
Hide Tsukamoto United States 9 349 0.8× 529 1.8× 572 3.4× 194 1.4× 148 1.5× 10 1.1k
A. Giménez Spain 14 129 0.3× 159 0.6× 379 2.3× 136 1.0× 47 0.5× 33 860
Ashwani K. Singal United States 14 321 0.7× 109 0.4× 516 3.1× 127 0.9× 52 0.5× 31 824
Mariarita Dessı̀ Italy 17 131 0.3× 166 0.6× 152 0.9× 173 1.3× 71 0.7× 34 780
J. C. Bode Germany 9 259 0.6× 231 0.8× 375 2.2× 119 0.9× 119 1.2× 11 722
Katja S. Salmela Finland 13 260 0.6× 121 0.4× 126 0.8× 171 1.2× 33 0.3× 24 511
Allan G. Halline United States 13 135 0.3× 190 0.7× 56 0.3× 102 0.7× 45 0.5× 29 526

Countries citing papers authored by K. Jokelainen

Since Specialization
Citations

This map shows the geographic impact of K. Jokelainen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Jokelainen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Jokelainen more than expected).

Fields of papers citing papers by K. Jokelainen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Jokelainen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Jokelainen. The network helps show where K. Jokelainen may publish in the future.

Co-authorship network of co-authors of K. Jokelainen

This figure shows the co-authorship network connecting the top 25 collaborators of K. Jokelainen. A scholar is included among the top collaborators of K. Jokelainen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Jokelainen. K. Jokelainen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Kylänpää, Leena, Harri Mustonen, Jorma Halttunen, et al.. (2012). Risk factors for complications of ERCP in primary sclerosing cholangitis. Endoscopy. 44(12). 1133–1138. 50 indexed citations
2.
Nanji, Amin A., K. Jokelainen, George Lau, et al.. (2001). Arginine Reverses Ethanol-Induced Inflammatory and Fibrotic Changes in Liver Despite Continued Ethanol Administration. Journal of Pharmacology and Experimental Therapeutics. 299(3). 832–839. 60 indexed citations
3.
Lindros, Kai O., et al.. (1999). Acetaldehyde prevents nuclear factor-kappa B activation and hepatic inflammation in ethanol-fed rats.. PubMed. 79(7). 799–806. 36 indexed citations
4.
Nosova, T., K. Jokelainen, Harri A. Järveläinen, Kai O. Lindros, & Mikko Salaspuro. (1998). HIGH BLOOD ENDOTOXIN DOES NOT AFFECT ETHANOL ELIMINATION IN RATS. Alcohol and Alcoholism. 33(5). 443–446. 3 indexed citations
5.
Nosova, T., K. Jokelainen, Pertti Kaihovaara, et al.. (1998). CHARACTERISTICS OF ALDEHYDE DEHYDROGENASES OF CERTAIN AEROBIC BACTERIA REPRESENTING HUMAN COLONIC FLORA. Alcohol and Alcoholism. 33(3). 273–280. 40 indexed citations
6.
Jokelainen, K., et al.. (1998). Inhibition of Intracolonic Acetaldehyde Production and Alcoholic Fermentation in Rats by Ciprofloxacin. Alcoholism Clinical and Experimental Research. 22(5). 1161–1164. 43 indexed citations
7.
Jokelainen, K., T. Nosova, Tiina Koivisto, et al.. (1997). INHIBITION OF BACTERIOCOLONIC PATHWAY FOR ETHANOL OXIDATION BY CIPROFLOXACIN IN RATS. Life Sciences. 61(18). 1755–1762. 18 indexed citations
8.
Koivisto, Tiina, et al.. (1997). Effects of Acetaldehyde on Cell Regeneration and Differentiation of the Upper Gastrointestinal Tract Mucosa. JNCI Journal of the National Cancer Institute. 89(22). 1692–1697. 105 indexed citations
9.
Nosova, T., Hannele Jousimies–Somer, Pertti Kaihovaara, et al.. (1997). Characteristics of Alcohol Dehydrogenases of Certain Aerobic Bacteria Representing Human Colonic Flora. Alcoholism Clinical and Experimental Research. 21(3). 489–494. 37 indexed citations
10.
Jokelainen, K., Tamara Matysiak‐Budnik, Heikki Mäkisalo, K. Höckerstedt, & Mikko Salaspuro. (1996). High intracolonic acetaldehyde values produced by a bacteriocolonic pathway for ethanol oxidation in piglets.. Gut. 39(1). 100–104. 75 indexed citations
11.
Nosova, T., K. Jokelainen, Pertti Kaihovaara, et al.. (1996). ALDEHYDE DEHYDROGENASE ACTIVITY AND ACETATE PRODUCTION BY AEROBIC BACTERIA REPRESENTING THE NORMAL FLORA OF HUMAN LARGE INTESTINE. Alcohol and Alcoholism. 31(6). 555–564. 59 indexed citations
12.
Jokelainen, K., et al.. (1996). Increased Acetaldehyde Production by Mouthwashings from Patients with Oral Cavity, Laryngeal, or Pharyngeal Cancer. Alcoholism Clinical and Experimental Research. 20(7). 1206–1210. 35 indexed citations
13.
Jokelainen, K., A. Siitonen, Hannele Jousimies–Somer, et al.. (1996). In Vitro Alcohol Dehydrogenase‐Mediated Acetaldehyde Production by Aerobic Bacteria Representing the Normal Colonic Flora in Man. Alcoholism Clinical and Experimental Research. 20(6). 967–972. 72 indexed citations
14.
Jokelainen, K., Risto P. Roine, Hannu Väänänen, Martti Färkkilâ, & Mikko Salaspuro. (1994). In vitro acetaldehyde formation by human colonic bacteria.. Gut. 35(9). 1271–1274. 82 indexed citations
15.
Salmela, Katja S., et al.. (1991). Serum dolichols in different clinical conditions. Scandinavian Journal of Clinical and Laboratory Investigation. 51(8). 705–709. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026